TABLE - US Labor Dept. jobless claims data
Reuters2026/10/08 12:36Oct 8 (Reuters) - U.S. Labor Department report of initial state jobless benefit claims, seasonally adjusted. Insured Unemployment Week Ended Initial Claims 4-Week Avg. Continued Claims rate (pct) 10/03/26 197,000 198,000 N/A N/A 09/26/26 199,000-R 200,500-R 1,716,000 1.1 09/19/26 198,000 202,500 1,699,000-R 1.1 09/12/26 198,000 204,000 1,712,000 1.1 PREVIOUSLY REPORTED ESTIMATES: Initial claims: Sept. 26 at 197,000; Sept. 19 at 198,000; Sept. 12 at 198,000 Four-week average: Sept. 26 at 200,000; Sept. 19 at 202,500; Sept. 12 at 204,000 Continued claims: Sept. 19 at 1,701,000; Sept. 12 at 1,712,000 Insured unemployment rate: Sept. 19 at 1.1 percent; Sept. 12 at 1.1 percent Reuters survey of U.S. economists' forecast: U.S. Initial Claims: 200,000 U.S. Continued Claims: 1.708 mln UNADJUSTED DATA: Week ended Initial claims Week ended Continued claims 10/03/26 170,333 09/26/26 1,504,800 09/26/26 158,339 09/19/26 1,497,221 NOTES: N/A - not available R - revised ((Washington newsroom))
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
